Please Register or Login to save this technology and benefit from all of Pharmalicensing's features.

Select to Save this to or Remove this from an Existing Collection

SJ-BRV Antiobesity Immunodrug_SJ BIOMED Inc

Korea Health Industry Development Institute (KHIDI)South Korea

Abstract ID:

SJ-BRV Antiobesity Immunodrug

Send an Inquiry

RE:

Participants

Could not send inquiry. Please sign-in and try again.

You

Subject

Message

SJ-BRV is novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity by controlling lipid metabolism in a stage of storage. The key to the SJ-BRV vaccine is to trick the immune system into making antibodies against self antigens. SJ-BRV works by eliciting antibodies that block the binding of lipids in receptors in the adipose tissue thus preventing lipid storage in the adipose tissue.